Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
Business Wire (Wed, 12-Mar 4:05 PM ET)
Weight-loss drug battle: Who are the latest players involved
Seeking Alpha News (Sat, 8-Mar 1:30 PM ET)
Business Wire (Tue, 4-Mar 4:05 PM ET)
Allurion to Participate in Upcoming Investor Conferences
Business Wire (Tue, 25-Feb 4:05 PM ET)
Business Wire (Thu, 20-Feb 4:05 PM ET)
Business Wire (Wed, 19-Feb 9:03 AM ET)
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
Business Wire (Tue, 18-Feb 8:30 AM ET)
Business Wire (Thu, 13-Feb 8:30 AM ET)
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
Business Wire (Fri, 24-Jan 9:30 AM ET)
Business Wire (Thu, 23-Jan 3:48 PM ET)
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Allurion Technologies trades on the NYSE stock market under the symbol ALUR.
As of March 13, 2025, ALUR stock price declined to $2.43 with 33,828 million shares trading.
ALUR has a beta of 4.32, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.07 to the broad based SPY ETF.
ALUR has a market cap of $14.48 million. This is considered a Sub-Micro Cap stock.
Last quarter Allurion Technologies reported $5 million in Revenue and -$3.50 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $1.00.
The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VTI, VXF, IWC.
ALUR has underperformed the market in the last year with a price return of -96.3% while the SPY ETF gained +7.8%. ALUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -71.9% and -30.4%, respectively, while the SPY returned -8.7% and -7.5%, respectively.
ALUR support price is $2.32 and resistance is $2.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.